Biotech

#Biotech #Biotech hubs #Drug discovery hotspots #Market reporting

Where are the global hotspots for biotech?

The future is looking rosy for the biotechnology sector. Diana Spencer takes a world-tour of some of the key centres of innovation.  According to data analysts Precedence Research, the global biotechnology market was estimated at $1.38 trillion in 2023 and is expected to be worth around $4.25 trillion by 2033,… Read More

#Business & Investment #Exclusive Content #Market Reports

#Biotech #Cell analysis #Drug discovery #Flow Cytometry

Improving on current challenges in cell analysis 

Dr Lindsay Fraser, Chief Science and Operations Officer, and Dr Fernanda Masri, Chief Commercial and Innovation Officer, at Cytomos explore current advances in technology that are helping improve cell analysis within drug discovery.   The biopharma industry is under increasing pressure to bring novel therapies to market, faster and more affordably. Read More

#Exclusive Content

#Biotech #Drug discovery #Funding #Investment #UK

Early-stage biotech investment: where are we? 

Yogan A Patel, Partner at MHA and Head of MHA’s Pharma, Life Science and Med-Tech sector group examines the investment landscape for early-stage biotech companies in the UK and further afield.   It is well recognised by both investors and government that the UK has huge strengths in biotechnology. Investment… Read More

#Exclusive Content

#Allogene Therapeutics #allogeneic cell therapies #Biologics #Biotech #Cancer Research Horizons #Cancer vaccine #CAR-T #Cell therapy #Clinical trials #Drug discovery #Financing #Funding #LifeArc #Oncology #Rare disease #Research and development #Seed funding #Start-ups #University of Dundee #University of Oxford

New DDW Highlights episode: 8 May 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The ongoing innovation and development in the drug discovery sector relies on a number… Read More

#News

#Allogene Therapeutics #allogeneic cell therapies #Biologics #Biotech #Cancer Research Horizons #Cancer vaccine #CAR-T #Cell therapy #Clinical trials #Drug discovery #Financing #Funding #LifeArc #Oncology #Rare disease #Research and development #Seed funding #Start-ups #University of Dundee #University of Oxford

This week in drug discovery (29 April – 3 May) 

News round-up for 29 April – 3 May by DDW Multimedia Editor Megan Thomas. The ongoing innovation and development in the drug discovery sector relies on a number of moving parts, one of which is financial support and backing. Whether it is successful seed funding or dedicated investment,… Read More

#News

GBP pound sterling funding
#Biotech #Cancer Research Horizons #Cancer vaccine #Oncology #Start-ups #University of Oxford

Cancer vaccine developer secures £12.8m

Oxford University spin-out Infinitopes Precision Immunomics has completed a £12.8 ($16) million seed funding round led by Octopus Ventures. The round was heavily oversubscribed, also drawing in funds from Cancer Research Horizons, Cancer Research Institute, CRIS Cancer Foundation, Kindred Capital, Manta Ray, Martlet Capital, Meltwind Advisory, Saras Capital, Wilbe Capital,… Read More

#Business & Investment #News #Start-up Zone

#Bios Health Group #Biotech #Biotech hubs #Collaboration #Life science #Start-ups

Bios launches biotech hub to support life science progress

Bios Health Group has launched the Bios Innovation Circle – a new venture studio and strategic hub, designed to support biotechnology and life science companies towards growing success. The Bios Innovation Circle is a venture studio and strategic hub designed to catalyse the growth of start-ups,… Read More

#News #Start-up Zone

A team working in a laboratory
#Biotech #Collaboration #Contract Research Organisations (CROs) #Drug discovery #Torx Software

Last chance to register: Enhancing collaboration in drug discovery

Join DDW and Cresset for this free event ‘Enhancing collaboration in drug discovery – a biotech perspective’. The event will take place on 28 March at 2pm GMT / 3pm CET / 9am EST / 6am PST. Delivery of synthesis targets… Read More

#News

Research laboratory
#Biotech #Collaboration #Contract Research Organisations (CROs) #Drug discovery #Torx Software

Webinar: Enhancing collaboration in drug discovery

Join DDW and Cresset for this free event ‘Enhancing collaboration in drug discovery – a biotech perspective’. The event will take place on 28 March at 2pm GMT / 3pm CET / 9am EST / 6am PST. Delivery of synthesis targets… Read More

#News

Team of scientists working in a lab
#Biotech #Collaboration #Contract Research Organisations (CROs) #Drug discovery #Torx Software

Webinar: Biotech experts share their tips for effective collaboration

Join DDW and Cresset for this free event ‘Enhancing collaboration in drug discovery – a biotech perspective’. The event will take place on 28 March at 2pm GMT / 3pm CET / 9am EST / 6am PST. Delivery of synthesis targets… Read More

#News

Team of scientists in the lab
#Biotech #Collaboration #Contract Research Organisations (CROs) #Drug discovery #Torx Software

Webinar: How to collaborate effectively across multiple teams

Join DDW and Cresset for this free event ‘Enhancing collaboration in drug discovery – a biotech perspective’. The event will take place on 28 March at 2pm GMT / 3pm CET / 9am EST / 6am PST. Delivery of synthesis targets… Read More

#News

A team working in a laboratory
#Biotech #Collaboration #Contract Research Organisations (CROs) #Drug discovery #Torx Software

Enhancing collaboration in drug discovery: Register now

Join DDW and Cresset for this free event ‘Enhancing collaboration in drug discovery – a biotech perspective’. The event will take place on 28 March at 2pm GMT / 3pm CET / 9am EST / 6am PST. Delivery of synthesis targets… Read More

#News

A team working in a laboratory
#Biotech #Collaboration #Drug discovery #Lab technology #Torx Software #Webinar

Enhancing collaboration in drug discovery – a biotech perspective

Delivery of synthesis targets within small molecule drug discovery often involves many chemists and other collaborators, both internal and external, across multiple locations. Harnessing skills and knowledge from distributed teams can create challenges for efficiently managing the ideation process and prioritisation, assignment and delivery of agreed targets. Read More

Webinar date:
Brought to you by Cresset
#Webinars

business deal
#Acquisition #Biotech #Drug development #Investment #Mergers and acquisitions

Novo Holdings acquires Catalent for $16.5 billion 

Catalent and Novo Holdings, a holding and investment company that manages the assets and wealth of the Novo Nordisk Foundation, have entered into a merger agreement under which Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5 billion.  Novo Holdings will acquire… Read More

#News

#BioIndustry Association #Biotech #Investment #Market reporting #UK

Buoyant UK biotech sector secures £1.8bn investment in 2023

The UK’s life sciences and biotech sector showed resilience in 2023, securing £1.8 ($2.2) billion in equity investment despite a challenging global economic climate, according to a report by the UK BioIndustry Association (BIA). This follows another BIA report in January 2024, which showed that the UK is a global… Read More

#Business & Investment #News

Cambridge, MA
#Arena BioWorks #Biomedical research #Biotech #Biotech hubs #Business #Private investment

Arena BioWorks launches with a unique business model

Arena BioWorks has launched as a biomedical research institute with a stated mission to uncover mechanisms of disease by engaging in basic biological research that will be translated into lifesaving biotech therapeutics. Arena BioWorks describes itself as a dual-purpose entity aimed at achieving social good and creating long-term sustainable impact… Read More

#Business & Investment #News